Baxter International Inc. (BAX) vs Halozyme Therapeutics, Inc. (HALO)
A side-by-side comparison of Baxter International Inc. and Halozyme Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BAX
Baxter International Inc.
$24.30HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
HALO
Halozyme Therapeutics, Inc.
$109.70HealthcareDelayed quote: Oct 6, 2026, 9:40 AM EDT
Total return — BAX vs HALO
growth of $100 · dividends reinvested · last 10yBAX -39.8% (-4.9%/yr)HALO +779.9% (+24.3%/yr)HALO compounded faster over this window
Log scale — wide-divergence pair
BAX HALO
BAX vs HALO: by the numbers
- •HALO is the larger company ($13.01B vs $12.56B market cap).
- •HALO is profitable (24.86% net margin) while BAX runs a net loss (-9.27%).
- •HALO grew revenue faster over the past five years (32.18% vs -1.22% CAGR).
- •BAX pays a dividend (0.17% yield), while HALO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BAX | HALO |
|---|---|---|
| P/E ratio | N/A | 32.75 |
| Forward P/E | 11.83 | 13.04 |
| PEG ratio | N/A | 1.43 |
| P/S ratio | 1.10 | 7.82 |
| P/B ratio | 2.02 | 90.65 |
| EV / EBITDA | 29.57 | 14.22 |
| FCF yield | 5.40% | 6.20% |
Profitability
| Metric | BAX | HALO |
|---|---|---|
| Gross margin | 30.08% | 78.18% |
| Operating margin | -2.39% | 56.77% |
| Net margin | -9.27% | 24.86% |
| ROE | -17.13% | 288.13% |
| ROIC | -1.61% | 27.42% |
Dividends
| Metric | BAX | HALO |
|---|---|---|
| Dividend yield | 0.17% | N/A |
Growth (annualized)
| Metric | BAX | HALO |
|---|---|---|
| Revenue CAGR (5Y) | -1.22% | 32.18% |
| EPS CAGR (5Y) | N/A | 22.68% |
| FCF CAGR (5Y) | -12.92% | 40.08% |
| Total return CAGR (5Y) | -19.87% | 22.18% |
Frequently asked
- Which has grown faster, BAX or HALO?
- Over the past five years, HALO grew revenue faster — BAX at a -1.22% CAGR versus HALO at 32.18%.
- Does BAX or HALO pay a bigger dividend?
- BAX pays a dividend (0.17% yield), while HALO has no payments in the available dividend history.
- Is BAX or HALO more profitable?
- HALO runs the higher net margin — BAX at -9.27% versus HALO at 24.86%.
- How have BAX and HALO total returns compared?
- Over the past 10 years, BAX delivered -5.15% and HALO delivered 24.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Halozyme Therapeutics P/E ratioBaxter International dividend yieldBaxter International ROEHalozyme Therapeutics ROEBaxter International operating marginHalozyme Therapeutics operating marginBaxter International revenue growthHalozyme Therapeutics revenue growthBaxter International free cash flowHalozyme Therapeutics free cash flow
Baxter International & Halozyme Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.